Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2014-10-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This intervention study will measure commuters' exposure to air pollutants in rush hour traffic. It will evaluate the impact of this exposure on stress hormones in saliva, and short term cardiopulmonary health indicators such as blood pressure, heart rate variability and respiratory inflammation. It will also look at effects on cognition (mental processing and judgement) in this real world environment where any deficit could be important to safety. In addition, the study will examine whether cabin air filtration can reduce the exposure to traffic related air pollutants and result in improvements in short term cardiopulmonary and cognitive function. This research will contribute to our understanding of how this environment contributes to Canadians' overall air pollution exposure as well as the potential health impacts. It will also test a potentially valuable and economical means of reducing exposure to traffic related air pollution in a commuting environment. The study may also guide the future implementation of the use of cabin filters as an exposure reduction intervention.
Overall Project Objectives:
Can cabin air filtration effectively reduce exposure to traffic related air pollution? Does commuter exposure to air pollution affect short term stress, and cardiopulmonary and cognitive function? Can cabin air filtration mitigate the health effects of commuters' exposure to air pollution?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Effects of Aerosols in Residences Study
NCT01570062
Air Pollution Reduction in the Elderly and Cardiovascular and Cognitive Outcomes
NCT02411240
Home Air Filtration for Traffic-Related Air Pollution
NCT04279249
Effect of Commute Traffic on Vascular Function
NCT05454930
Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors
NCT04103346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Participants are exposed to unfiltered cabin air
Placebo
No Cabin Air Filtration
Cabin Air Filter
Participants are exposed to filtered cabin air
Cabin Air Filtration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cabin Air Filtration
Placebo
No Cabin Air Filtration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-smoking.
Exclusion Criteria
* living in a smoking household;
* currently experiencing seasonal allergies;
* suffering from heart rhythm problems or heart conditions;
* regularly taking corticosteroid medication;
* pregnant or breastfeeding;
* allergic to latex;
* sensitivity to adhesives
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health Canada
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gary Mallach
Air Health Effects Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Mallach
Role: PRINCIPAL_INVESTIGATOR
Health Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guy-Favreau Complex
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB 2014-0006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.